http://www.catalystpharma.com
Catalyst Pharmaceuticals, Inc. Company Intro
Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.
Industry
Healthcare
Catalyst Pharmaceuticals, Inc. Headquaters
355 Alhambra Circle
Coral Gables,33134
United States
Catalyst Pharmaceuticals, Inc. Share price
17 May 2023 13:00 GMT
$12.88
-0.26 (-1.98 %)
Catalyst Pharmaceuticals, Inc. Market cap
$1.327 B
WMC RANKING
2024
Catalyst Pharmaceuticals, Inc. # 70
BiotechnologyLatest Catalyst Pharmaceuticals, Inc. News
12 Feb 2024
Barclays PLC Has $3.87 Million Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Barclays PLC decreased its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 50.1% in the 3rd quarter, according to the...
12 Feb 2024
Barclays PLC Has $3.87 Million Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Barclays PLC decreased its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 50.1% in the 3rd quarter, according to the...
10 Feb 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Purchased by Jupiter Asset Management Ltd.
Jupiter Asset Management Ltd. grew its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 64.0% during the third quarter,...
WMC Market Score
WMC Market to Revenue Score
Catalyst Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Catalyst Pharmaceuticals, Inc. | USD | $120,141 | $62,167 | $72,220 | $13,270B | 70 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Catalyst Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Catalyst Pharmaceuticals, Inc. | 1.31 | 2.08 | 0.03 | 0 | 0 | 0 | 0.75 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
